Abstract

Rhabdomyolysis is a potentially life‐threatening syndrome. Destruction of muscle fibers secondary to disruption of calcium homeostasis in muscle cells allows leakage of toxic cellular contents into the systemic circulation, resulting in fiber necrosis. Significant elevation of serum creatine kinase usually occurs in patients with rhabdomyolysis. This case report describes a patient who developed rhabdomyolysis after receiving concurrent risperidone and escitalopram.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.